NCT03967886View on ClinicalTrials.gov

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

May 27, 2020

Conditions
Non-erosive Reflux Disease
Interventions
DRUG

YYD601 20mg

Patients should take drugs an hour before breakfast.

DRUG

Nexium 20mg

Patients should take drugs an hour before breakfast.

DRUG

Placebos

The placebo YYD601 is made from microcrystalline cellulose covered with hard shell. The placebo Nexium is made from microcrystalline cellulose, Crospovidone, Magnesiumstearat and other ingredients.

Trial Locations (1)

Unknown

Korea University Ansan Hospital, Seoul

All Listed Sponsors
lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT03967886 - Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients | Biotech Hunter | Biotech Hunter